Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
Providing smart automation tools along with bolstered image quality, the newly launched Flash 5100 POC ultrasound system may help bridge the gap between novice ultrasound evaluation and expert reading in time-sensitive environments such as critical care and emergency medicine.
Facilitating workflow efficiencies in demanding environments such as intensive care and trauma units, the Flash 5100 point-of-care modality emphasizes intuitive touchscreen controls, automated features and the capability to perform and document exams in real time, according to Philips, the manufacturer of the ultrasound device.
In addition to intuitive touchscreen controls and automated features, the newly launched Flash 5100 POC ultrasound system has built-in tele-ultrasound support with Collaboration Live, which enables real-time consults with remote colleagues through shared screens and images. (Photo courtesy of Philips.)
Philips said the Flash 5100 POC ultrasound system also has built-in tele-ultrasound support with Collaboration Live, which enables real-time collaboration with remote colleagues through shared screens and images.
The system’s cross-platform transducer compatibility, featuring the mL26-8 transducer, facilitates an array of musculoskeletal applications, according to Philips.
“Designed for speed, mobility, and precision, (the Flash 5100 POC ultrasound system) empowers clinicians to make confident, real-time decisions in the most urgent settings — at the bedside, in the ICU, the emergency department, or the OR. With advanced algorithms and smart automation, Flash 5100 POC delivers the critical insights clinicians need when and where they need them most,” posited Jeff Cohen, the global business leader of ultrasound at Philips.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.